V-BIOTEK AF 13. JUNI 2006 ApS: Financial statements 2015
CVR: 29617805
Source: annual report 2015, Danish Business Authority
01/07/2014 – 30/06/2015
V-BIOTEK AF 13. JUNI 2006 ApS (CVR 29617805) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -5,000 and a net result of DKK -888 compared with DKK -1,025 the year before. Equity in the 2015 report amounted to DKK 101,359. The solvency ratio was 69.4%.
- Gross Profit
- DKK -5,000
- Profit/Loss
- DKK -888
- Equity
- DKK 101,359
- Total Assets
- DKK 146,054
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -5K | -888 | 101K | - |
| 2014 | - | -5K | -1K | 102K | - |
| 2013 | - | -5K | -1K | 103K | - |
Official annual report
How creditworthy is V-BIOTEK AF 13. JUNI 2006 ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of November 19, 2015, VKST REVISION, GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of V-BIOTEK AF 13. JUNI 2006 ApS.
As of February 3, 2015, VKST REVISION, GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of V-BIOTEK AF 13. JUNI 2006 ApS.
As of February 3, 2015, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of V-BIOTEK AF 13. JUNI 2006 ApS.
About V-BIOTEK AF 13. JUNI 2006 ApS
V-BIOTEK AF 13. JUNI 2006 ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2006. The company has been dissolved on 8 December 2016. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named TWL2 ApS and DAMHUS II ApS. In 2016, the company reported a gross profit of DKK -14,188 and a net result of DKK -10,070 compared with DKK -888 the year before. Equity in the 2016 report amounted to DKK 91,289.